SCHEMBL1454571

SCHEMBL1454571

C[CH]CC(C)Oc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.47
MTNR1B P49286 1/20 0.47
LMNA P02545 1/20 0.39
CHRNB4 P30926 2/20 0.39
CHRNA3 P32297 2/20 0.39
LTA4H P09960 1/20 0.38
POLB P06746 1/20 0.37
KDM4E B2RXH2 1/20 0.37
SLC6A4 P31645 1/20 0.37
MAOA P21397 2/20 0.36
PTGS1 P23219 1/20 0.36
CA4 P22748 1/20 0.36
CYP1A2 P05177 1/20 0.35
GAA P10253 1/20 0.35
CYP2C9 P11712 1/20 0.35
PKM P14618 1/20 0.35
CYP2C19 P33261 1/20 0.35
ADRA2A P08913 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2853850 0.84 MTNR1A (0.45) MTNR1AMTNR1BLMNACHRNB4CHRNA3
SCHEMBL11516903 0.82 MTNR1A (0.46) MTNR1AMTNR1BLMNACHRNB4CHRNA3
SCHEMBL4633428 0.82 MTNR1A (0.46) MTNR1AMTNR1BLMNACHRNB4CHRNA3
SCHEMBL8733440 0.82 MTNR1A (0.50) MTNR1AMTNR1BLMNACHRNB4CHRNA3
SCHEMBL1454117 0.81 SLC6A4 (0.38) MTNR1AMTNR1BLMNACHRNB4CHRNA3
SCHEMBL1455296 0.80 MTNR1A (0.45) MTNR1AMTNR1BLMNACHRNB4CHRNA3
SCHEMBL27526890 0.79 MTNR1A (0.44) MTNR1AMTNR1BLMNACHRNB4CHRNA3
SCHEMBL9870647 0.78 MTNR1A (0.53) MTNR1AMTNR1BLMNACHRNB4CHRNA3
SCHEMBL9870637 0.78 MTNR1A (0.53) MTNR1AMTNR1BLMNACHRNB4CHRNA3
SCHEMBL1454212 0.77 MTNR1A (0.42) MTNR1AMTNR1BLMNACHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7910617-B2 Method for suppressing the number of peripheral blood lymphocytes using an amino alcohol compound SANKYO COMPANY, LIMITED (JP) 2011-03-22 US disclosed
US-20070191468-A1 Amino alcohol compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2007-08-16 US disclosed
EP-1733724-A1 AMINO ALCOHOL COMPOUND Sankyo Company, Limited (JP) 2006-12-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191468-A1 Amino alcohol compound ADH1A, ADH1C, BCAT1 MTNR1A 3312/4885MTNR1B 2386/4885LMNA 3709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.